Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Foreign Blend
  • Asset Class: Equity
  • Geographic Focus: Global

GaveKal Knowledge Leaders Fund

+ Add to Watchlist

GAVAX:US

14.57 USD 0.000.00%

As of 09:29:30 ET on 04/24/2015.

Snapshot for GaveKal Knowledge Leaders Fund (GAVAX)

Year To Date: +6.90% 3-Month: +4.90% 3-Year: +11.45% 52-Week Range: 12.75 - 14.58
1-Month: +0.14% 1-Year: +12.25% 5-Year: - Beta vs MXWO: 0.79

Mutual Fund Chart for GAVAX

No chart data available.
  • GAVAX:US 14.57
  • 1M
  • 1Y
Interactive GAVAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for GAVAX

GaveKal Knowledge Leaders Fund is an open-end fund incorporated in the USA. The objective is to seek long-term growth of capital. The Fund will invest in common stock of companies throughout the world that the advisor considers to be companies that incorporate knowledge components, or intellectual property, into their products and services.

Inception Date: 09-30-2010 Telephone: -
Managers: STEVEN C VANNELLI "STEVE"
Web Site: -

Fundamentals for GAVAX

NAV (on 2015-04-24) 14.57
Assets (M) (on 2015-04-24) 196.07
Fund Leveraged N
Minimum Investment 2,500.00
Minimum Subsequent Investment 250.00

Dividends for GAVAX

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-12-09) 0.04
Dividend Yield (ttm) 2.40

Fees & Expenses for GAVAX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.90
Redemption Fee 2.00
12b1 Fee 0.25
Expense Ratio 1.45

Top Fund Holdings for GAVAX

Filing Date: 03/31/2015
Name Position Value % of Total
iShares Short Treasury Bond ET 86,298 9,516,080 4.913%
SPDR Barclays 1-3 Month T-Bill 208,054 9,514,309 4.912%
Becton Dickinson and Co 33,553 4,817,875 2.487%
Laboratory Corp of America Hol 37,036 4,669,869 2.411%
Quest Diagnostics Inc 58,679 4,509,481 2.328%
Bristol-Myers Squibb Co 63,594 4,101,813 2.118%
Eli Lilly & Co 55,797 4,053,652 2.093%
Medtronic PLC 51,710 4,032,863 2.082%
iShares 20+ Year Treasury Bond 30,548 3,992,318 2.061%
Zimmer Holdings Inc 33,847 3,977,699 2.054%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil